Entheon Biomedical Corp. announced earnings results for the second quarter ended May 31, 2021. For the second quarter, the company announced net loss was CAD 2.413 million compared to CAD 371,552 a year ago. Basic loss per share from continuing operations was CAD 0.04 compared to CAD 0.01 a year ago. For the half year, net loss was CAD 5.297 million compared to CAD 740,399 a year ago. Basic loss per share from continuing operations was CAD 0.1 compared to CAD 0.03 a year ago.